Allianz Asset Management GmbH - ALDER BIOPHARMACEUTICALS INC ownership

ALDER BIOPHARMACEUTICALS INC's ticker is ALDR and the CUSIP is 014339105. A total of 130 filers reported holding ALDER BIOPHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 0.98 and the average weighting 0.3%.

Quarter-by-quarter ownership
Allianz Asset Management GmbH ownership history of ALDER BIOPHARMACEUTICALS INC
ValueSharesWeighting
Q2 2019$466,000
-19.0%
39,629
-5.8%
0.00%
-100.0%
Q1 2019$575,000
+49.7%
42,081
+12.0%
0.00%
Q4 2018$384,000
+4.1%
37,575
+69.9%
0.00%
Q3 2018$369,000
+5.7%
22,1100.0%0.00%
Q2 2018$349,000
+24.2%
22,1100.0%0.00%
Q1 2018$281,000
+11.1%
22,1100.0%0.00%
Q4 2017$253,000
-6.6%
22,1100.0%0.00%
Q3 2017$271,000
+8.4%
22,110
+6.2%
0.00%
Q2 2017$250,000
-43.3%
20,810
-1.4%
0.00%
Q1 2017$441,000
-38.0%
21,100
-38.2%
0.00%
-100.0%
Q4 2016$711,000
-68.9%
34,161
-51.7%
0.00%
-50.0%
Q3 2016$2,288,000
+52.3%
70,698
+17.5%
0.00%0.0%
Q2 2016$1,502,000
+205.3%
60,167
+199.2%
0.00%
+100.0%
Q1 2016$492,000
-23.6%
20,112
+5.5%
0.00%0.0%
Q4 2015$644,000
+3.0%
19,0700.0%0.00%0.0%
Q3 2015$625,000
-47.7%
19,070
-15.5%
0.00%0.0%
Q2 2015$1,196,00022,5700.00%
Other shareholders
ALDER BIOPHARMACEUTICALS INC shareholders Q2 2019
NameSharesValueWeighting ↓
Foresite Capital Management III, LLC 2,942,130$37,365,0008.14%
Foresite Capital Management II, LLC 1,686,220$21,415,0007.12%
Foresite Capital Management IV, LLC 830,919$10,553,0004.38%
SENZAR ASSET MANAGEMENT, LLC 822,890$10,451,0003.30%
Redmile Group, LLC 6,505,766$82,623,0003.19%
DAFNA Capital Management LLC 396,013$5,029,0002.45%
SECTORAL ASSET MANAGEMENT INC 863,600$10,968,0001.20%
Palo Alto Investors LP 1,849,832$23,493,0001.00%
Bellevue Group AG 700,464$8,896,0000.88%
Rock Springs Capital Management LP 1,529,800$19,428,0000.83%
View complete list of ALDER BIOPHARMACEUTICALS INC shareholders